KNOW ESSENTIALS: A tool for informed decisions in the absence of formal HTA systems

International Journal of Technology Assessment in Health Care

Volumn 27, Issue 2, 2011, Pages 139-150

  Mathew, Joseph L ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Decision making; Developing countries; Evidence based medicine; Health technology assessment

Indexed keywords

EVIDENCE-BASED MEDICINE; HEALTH CARE PROFESSIONALS; HEALTH TECHNOLOGY; HEALTH TECHNOLOGY ASSESSMENT; HEALTH TECHNOLOGY ASSESSMENTS; HEALTH-CARE SYSTEM; INFORMED DECISION; LITERATURE SEARCH; NEW MODEL; PERSONAL EXPERIENCE;

DEVELOPING COUNTRIES; HEALTH; HEALTH CARE; RATING; TECHNOLOGY;

DECISION MAKING;

ARTICLE; ECONOMIC ASPECT; EVIDENCE BASED PRACTICE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH TEACHNOLOGY ASSESSMENT; ATTITUDE TO HEALTH; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL PRACTICE; DECISION MAKING; DECISION SUPPORT SYSTEM; DEVELOPING COUNTRY; ECONOMICS; EVIDENCE BASED MEDICINE; HUMAN; REVIEW;

DECISION MAKING; DECISION SUPPORT SYSTEMS, CLINICAL; DEVELOPING COUNTRIES; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 79961110768     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462311000109     Document Type: Article

References (49)

1. Anon. Health technology assessment. http://www.inahta.org/HTA/ (accessed November 28, 2010).
2. Anon. Pneumonia: The forgotten killer of children. The United Nations Children's Fund (UNICEF)/World Health Organization (WHO), 2006.
3. Begg CB, Berlin JA. Publication bias: A problem in interpreting medical data. J R Stat Soc. 1998;151:419-463.
4. Booth A. How much searching is enough? Comprehensive versus optimal retrieval for technology assessments. Int J Technol Assess Health Care. 2010;26:431-435.
5. Chalkidou K, Levine R, Dillon A. Helping poorer countries make locally informed health decisions. BMJ. 2010;341:c3651.
6. Doherty T, Chopra M, Jackson D, et al. Effectiveness of the WHO/UNICEF guidelines on infant feeding for HIV-positive women: Results from a prospective cohort study in South Africa. AIDS. 2007;21:1791-1797.
7. Droste S, Dintsios C, Gerber A. Information on ethical issues in health technology assessment: How and where to find them. Int J Technol Assess Health Care. 2010;26:441-449.
8. Drummond MF, Schwartz JS, Jönsson B, et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24:244-258.
9. Ehlers L, Vestergaard M, Kidholm K, et al. Doing mini-health technology assessments in hospitals: A new concept of decision support in health care? Int J Technol Assess Health Care. 2006;22:295-301.
10. EUnetHTA Work Package 8. EUnetHTA handbook on health technology assessment capacity building. Barcelona (Spain): Catalan Agency for Health Technology Assessment and Research. Catalan Health Service. Department of Health Autonomous Government of Catalonia; 2008.
11. EUnetHTA Work Package 4. HTA Core ModelTM for Diagnostic Technologies v. 1.0r; 2008. http://www.eunethta.net/Public/Work-Packages/EUnetHTA-Project-2006- 08/EUnetHTA-Deliverables-project-2006-2008/ (accessed October 27, 2010).
12. EUnetHTA Work Package 4. HTA Core ModelTM for Medical and Surgical Interventions v. 1.0r; 2008. http://www.eunethta.net/Public/Work-Packages/ EUnetHTA-Project-2006-08/EUnetHTA-Deliverables-project-2006-2008/ (accessed October 27, 2010).
13. EVIPNet. http://www.evipnet.org/modules/dia/ (accessed November 15, 2010).
14. Glanville J, Paisley S. Identifying economic evaluations for health technology assessment. Int J Technol Assess Health Care. 2010;26:436-440.
15. Hailey D. Commentary on the article "Key principles for the improved conduct of health technology assessments for resource allocation decisions". Int J Technol Assess Health Care. 2008;24:365-366.
16. Hailey D, Corabian P, Harstall C, Schneider W. The use and impact of rapid health technology assessments. Int J Technol Assess Health Care. 2000;16:651-656.
17. Huda SN, Shahab T, Ali SM, Afzal K, Khan HM. Acomparative clinical trial of artemether and quinine in children with severe malaria. Indian Pediatr. 2003;40:939-945.
18. INAHTA (International Network of Agencies for Health Technology Assessment), Ethics Working Group. INAHTA's working group on handling ethical issues: Final report. Stockholm: SBU; 2005.
19. Indian Academy Of Pediatrics Committee on Immunization (IAPCOI). Recommendations on immunization, 2008. Indian Pediatr. 2008;45:635-648.
20. Infectious Diseases Chapter, Indian Academy of Pediatrics. Management of malaria in children: Update 2008. Indian Pediatr. 2008;45:731-735.
21. Jones KL, Donegan S, Lalloo DG. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev. 2007;4:CD005967.
22. Kahveci R, Meads C. Analysis of strengths, weaknesses, opportunities, and threats in the development of a health technology assessment program in Turkey. Int J Technol Assess Health Care. 2008;24:235-240.
23. Kundu R, Ganguly N, Ghosh TK, Choudhury P, Shah RC. Diagnosis and management of malaria in children. Recommendations and IAP plan of action. Indian Pediatr. 2005;42:1101-1114.
24. Mathew JL. Pneumococcal vaccination in developing countries: Where does science end and commerce begin? Vaccine. 2009;27:4247-4251.
25. Mathew JL. Testing the feasibility of KNOW ESSENTIALS - an algorithm for informed decision-making in the absence of formal HTA. Oral presentation at HTAi 7th Annual Meeting, Dublin, Ireland, 2010.
26. Mathew JL. Artemisinin derivatives versus quinine for severe malaria in children: A systematic review and meta-analysis. Indian Pediatr. 2010;47:423-428.
27. McGregor M, Brophy JM. End-user involvement in health technology assessment (HTA) development: A way to increase impact. Int J Technol Assess Health Care. 2005;21:263-267.
28. McIntosh H, Olliaro P. Artemisinin derivatives for treating severe malaria. Cochrane Database Syst Rev. 2000;2:CD000527.
29. Mittal SK, Mathew JL. Polio eradication in India: The way forward. Indian J Pediatr. 2007;74:153-160.
30. Mohanty AK, Rath BK, Mohanty R, Samal AK, Mishra K. Randomized control trial of quinine and artesunate in complicated malaria. Indian J Pediatr. 2004;71:291-295.
31. National Malaria Eradication Programme. http://www.mrcindia.org/ Guidelines-for-Diagnosis2010.pdf (accessed May 10, 2010).
32. Oxman AD, Yohannes AM, Røttingen J. Options for improving malaria treatment: Introduction. Int J Technol Assess Health Care. 2010;26:228.
33. Phuong CXT, Bethell DB, Phuong PT, et al. Comparison of artemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malaria. Trans R Soc Trop Med Hyg. 1997;91:335-342.
34. Pichon-Riviere A, Augustovski F, Rubinstein A, et al. Health technology assessment for resource allocation decisions: Are key principles relevant for Latin America? Int J Technol Assess Health Care. 2010;26:421-427.
35. Piñeros M, Wiesner C, Cortés C, Trujillo LM. HPV vaccine introduction at the local level in a developing country: Attitudes and criteria among key actors. Cad Saude Publica. 2010;26:900-908.
36. Republic of Rwanda, Ministry of Financial Planning, Ministry of Health. Scaling up to achieve the health MDGs in Rwanda. 2006. www.oecd.org/dataoecd/34/ 39/37759625.pdf (accessed May 16, 2009).
37. Rollins NC, Becquet R, Bland RM, et al. Infant feeding, HIV transmission and mortality at 18 months: The need for appropriate choices by mothers and prioritization within programmes. AIDS. 2008;22:2349-2357.
38. Seoane-Vazquez E, Rodriguez-Monguio R. Negotiating antiretroviral drug prices: The experience of the Andean countries. Health Policy Plan. 2007;22:63-72.
39. Taylor TE, Wills BA, Courval JM, Molyneux ME. Intramuscular artemether vs intravenous quinine: An open, randomized trial in Malawian children with cerebral malaria. Trop Med Int Health. 1998;3:3-8.
40. Teerawattananon Y, Tantivess S, Yothasamut J, Kingkaew P, Chaisiri K. Historical development of health technology assessment in Thailand. Int J Technol Assess Health Care. 2009;25(Suppl 1):241-252.
41. Thuma PE, Bhat GJ, Mabeza GF, et al. A randomized controlled trial of artemotil (beta-arteether) in Zambian children with cerebral malaria. Am J Trop Med Hyg. 2000;62:524-529.
42. Vancelik S, Beyhun NE, Acemoglu H, Calikoglu O. Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey. BMC Public Health. 2007;7:122.
43. Wang S, Moss JR, Hiller JE. Applicability and transferability of interventions in evidence-based public health. Health Promot Int. 2006;21:76-83.
44. Watt A, Cameron A, Sturm L, et al. Rapid reviews versus full systematic reviews: An inventory of current methods and practice in health technology assessment. Int J Technol Assess Health Care. 2008;24:133-139.
45. Williamson NE, Liku J, McLoughlin K, Nyamongo IK, Nakayima F. A qualitative study of condom use among married couples in Kampala, Uganda. Reprod Health Matters. 2006;14:89-98.
46. Wecker JR, Phillips DC, Hayes J. Rotavirus vaccines: The role of researchers in moving evidence to action. Vaccine. 2009;27(Suppl 5):F4-F6.
47. WHO Global burden of disease initiative. www.who.int/healthinfo/global- burden-disease/about/en/index.html (accessed October 29, 2010).
48. World Health Organization. Guidelines for the treatment of malaria. Second Edition. World Health Organization, 2010. http://www.rollbackmalaria.org/ docs/hbsm.pdf (accessed March 25, 2010).
49. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000;94(Suppl 1):S1-S90.